This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Explains Devitt: If Im going to extract or source Delta-9 THC from hemp rather than [high-resin] cannabis, Im going to need around 50 times more biomass, which means 50 times more acreage, 50 times more labor, 50 times more water, et cetera, et cetera, [to make a small amount of THC distillate.] Hemp not really hemp Speaking in a Feb.
Khon Kaen University has experts and researchers working at the Cannabis Research Institute of the University. Experts at Khon Kaen University (KKU) in Thailand recently gathered to discuss research and academic collaboration related to hemp extraction in order to develop hemp products.
Before we dive into the research, here’s the lowdown: Important takeaway points on cannabis and cancer Your situation is unique. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. 1 So can cannabis cure cancer?
The vast majority of the existing research is on how specific cannabinoids kill cancer, but a growing body of work is revealing how the entourage of compounds found in whole-plant cannabis kills cancer. Without increased blood flow, the tumor does not have enough nutrition to sustain its development.
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?
Hemp in Italy: Law, Research, and Industry. The hemp sector in Italy has experienced important developments since that time; between laws and decrees, and above all, judgments and interpretations of the competent authorities. We apply our entirely subjective bong score to each event. CLE Webinar. Wednesday, July 28th, 11 a.m.
Inhalation of cannabis extracts allows for a faster onset and higher bioavailability than tinctures and oils, and now that doctors can monitor a patient’s metered-dosage, more accurate patient data. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.
New cannabis research found that a cannabis-based drug was able to kill pancreatic cancer cells. This cannabis-based drug, or rather miraculous medication, is a botanical combination of extracts from the Cyathus striatus fungus and cannabis. Then, the combination of the cannabinoid and fungal extract composition was examined.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
The National Football League has taken proactive steps moving forward into the future with a research grant to explore potential therapeutic attributes of CBD, cannabis, and other options to treat pain other than opioids. NFL Research Grant Will Invest in a Bright Future for Athletes and Others. The opioid epidemic is real.
This explosion of interest in the use of cannabis and CBD for animals has led to the development of a multi-million dollar industry creating cannabis-based products for pets. For years, hemp companies have been producing CBD rich extracts and marketing them for animals and humans. Related story.
One in 26 people will develop epilepsy in their lifetime. Medical marijuana can alleviate certain side effects and, some research indicates, reduce the number of seizures a patient experiences. National Geographic Magazine examined the role of CBD rich cannabis extracts in the use of seizure maintenance in children.
Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].
The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?
The German government is now funding cannabis research on cannabinoid extractions and additives to food. It is easy to categorize this development in the big bucket of the times they are a’changing—and at a rather rapid pace. That is a big story. . However, here is the strange dichotomy at play within the German government.
The lack of research is one of the many reasons that cannabis remains federally illegal. But one of the barriers to conducting the necessary research is its federally illegal status. These intertwining factors plaguing cannabis research must be eradicated for the sake of medical cannabis consumers. . Residue Solvents.
These findings were unearthed in a study titled “Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys,” carried out at the Mason Research Institute in Worcester Massachusetts in 1973. The study compared herculean doses of delta-8 THC to delta-9 THC, and a crude marijuana extract (CME), which is something similar to RSO.
Their goal was to disrupt the hemp extract market by breeding CBD-rich plants derived from medicinal cannabis plants that would replace the low-cannabinoid, low-terpene producing fibrous hemp plants that were being used to make extracts. Lastly, Dr. Crawford discussed OregonCBD’s newest cultivar group, CBG-rich plants (Type IV).
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
A team of University of Oregon-affiliated researchers has uncovered an unlikely tool in the fight against COVID-19. ” Both cannabinoid acids are safe for human consumption and can be abundantly found in hemp and its extracts. Further research is still needed before any substantial claims can be made.
Research Cluster with expert faculty members from various fields, as well as the first and only Drug Dependence Research Center in the country which is certified by the World Health Organization (WHO) Collaborating Center for Research and Training in Drug Dependence. Companies such as Bloom Medica Co.,
From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development. He has guided clients on license applications, facility design and build out, equipment installation and optimization, and plant oil extraction for cannabis and hemp processing facilities.
By: James Holley, Molecular Biologist, Scientific Officer, Mike Robinson, Co-founder, Research Institute, and Dr. David Ostrow, M.D., Research Director. International Cannabinoid Cancer Research Institute (Draft 5). An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.
The article provides a comprehensive overview of Rick Simpson Oil (RSO), a celebrated cannabis extract known for its full-spectrum composition and potential therapeutic benefits. Developed by Rick Simpson after his personal health struggles, RSO has attracted both acclaim and skepticism.
Australia’s Commonwealth Scientific and Industrial Research Organisation has been issued a licence to conduct research into psychedelic drug treatments. In an announcement on 18 May, CSIRO said it was moving into the research area to investigate the use of psychedelic drugs in treating mental illness. Read more subscribers only.
Both companies’ research and development teams are currently working on creating the products, which will incorporate other nutritional supplements such as vitamins, minerals, amino acids, and plants. According to NoCamels , the products will come in a gel tablet or pill format and will be sold over the counter at pharmacies.
To comply with these CBD standards, all Hemp CBD products sold at Sephora must: Exclusively contain full-spectrum or broad-spectrum Hemp CBD extracts, no isolate. According to an August 2019 report released by Grand View Research, Inc., We’ll continue to update you on any other regulatory development via this blog.
The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.
(OTC PINK:CBGL), an innovation-oriented company investing in disruptive cannabis technologies, today announces an important enhancement to its cannabis product manufacturing capabilities at its Natural Plant Extract of California facility in Lynwood, a suburb of Los Angeles.
Filament Health partnered with TrPR Psychedelic Research Program at UCSF to advance drug candidates through clinical trials. a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development. Industry Developments. CSE: NOVA). via KABC.
11,110,372, covering a method of extracting and isolating compounds from the plants of the Cannabis genus at low temperature using cold organic solvents. Leveraging this patent, the Company plans to pursue licensing opportunities for its unique extraction process with manufacturers. About Neptune Wellness Solutions Inc.
This issue is compounded when veterans do, on rare occasions, ask their doctors about medical marijuana, only to be treated as if they are mentally unstable or receive no specific health information at all,” the researchers found. This directly conflicts with past research claiming marijuana increases PTSD symptom severity.”.
Trait”) — a global leader in cannabinoid research focused on developing technologies that enable the production of safe, high-quality, predictable, and efficacious CBD products — today announced the completion of a C$31 million Series A financing round (the “Financing”). ” src=”cid:image004.jpg@01D7629A.47F4A520″
A major component of the program will be the development of new ways to infuse both the psychedelic compounds and fungi components into products to both improve bioavailability and to mask the bitter tastes of the fungus and its components.
The National Institute of Drug Abuse (NIDA) announced it would be setting the new standard of tetrahydrocannabinol ( THC ) at 5mg for cannabis research. NIDA is “a federal scientific research institute under the National Institutes of Health (NIH)”. It was reported that this new standard would take effect immediately.
Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).
HHC was synthesized in Adams’ laboratory as part of research to understand the active compounds in the cannabis plant. The importance of this finding is that, similar to CBN, HHC may occur naturally as a degradation product in aged cannabis, extracts, and concentrates. Hexahydrocannabinol (HHC). What is hydrogenation?
Cannabichromene (CBC) is a trace, high-value cannabinoid with great therapeutic potential, one of the most prominent in medical research. Medical research has shown CBC’s role in healing different physiological processes, such as an anti-inflammatory agent, treatment for neurological disorders, and even hypothermia.”.
With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.
Denver is expanding Alzheimer’s research through the efforts of local company MedPharm. . The company plans to move forward with research efforts through a special Schedule I Researcher Licenses given specifically to the company by the Drug Enforcement Administration. Denver Company Moves Forward with Research License .
After over four years of observation, the researchers found no traces of Chronic Obstructive Pulmonary Disease (COPD) —a condition commonly associated with tobacco smoking, characterized by coughing and shortness of breath—whether in developmental or advanced stages.
Desai brings to Ehave the ability to visualize opportunities and execute creative strategic solutions, while developing deep networks and relationships within the industry. Research in the area of mental health has been Dr. Nitin Desai’s passion. Ben Kaplan, CEO of Ehave, Inc.
Instead, the raw cannabis must be prepared to activate the cannabinoids (THC and CBD) by extraction initiated via heating. The extracted cannabinoids dissolve into an oily liquid, which can be used for baking. Research shows the non-active parent compound THCA converts more quickly into THC compared to CBDA converting to CBD.
Kanabo is an established leader in medical cannabis research and innovation. ABOUT KANABO GROUP PLC: Kanabo is an industry leader in product development and commercialisation of both cannabis-derived products for medical patients and THC-free products for CBD consumers.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content